GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3

Analyse Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7DVL
Type
protein
Length
812 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BONT/A3
UniProt
D3IV24
Ligands
ZN
Pockets
9 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABONT/A3protein40531% helix, 20% strandD3IV24
BBONT/A3protein40732% helix, 20% strandD3IV24

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110670.810.82113empty
25520.690.7841empty
35260.680.7840empty
4810.440.8019empty
5730.420.8016empty

Interfaces

1 interface between chains.

  • A–B · 769 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 7DVL · Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Subtype A3 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.